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Association of potentially
inappropriate medications with
outcomes of inpatient geriatric
rehabilitation
A prospective cohort study
Introduction
The proportion of older people in west-
ern countries is increasing. Higher age
is associated with multimorbidity, which
is a widespread medical problem often
leading to polypharmacy. Polypharmacy
is associated with an increased risk of
prescription of potentially inappropriate
medications (PIM). This study investi-
gated whether PIM have an association
with rehabilitation outcomes of an inpa-
tient geriatric rehabilitation in Switzer-
land. The use of PIM is often found in
a population of older persons [7, 16],
and may include medications that are
not indicated, which are not correctly
prescribed, or which are not appropriate
for elderly people. In an evaluation of
medication use over a period of 7 days,
Fialová et al. showed that over 95% of
elderly persons took at least one medica-
tion and polypharmacy was documented
in 51% of the patients [7]. At least one
potentially inappropriate drug was taken
by 19.8% of the patients. Frequently pre-
scribedPIMswerevasodilators, benzodi-
azepines, heart medication, antidepres-
sants and anticoagulants (e. g. warfarin)
and PIMs were associated with an age of
75–79 years, frailty and polypharmacy
[21]. Frail people are at increased risk of
adverse drug events, e. g. falls, hospital-
ization and mortality. Landi et al. have
shown that PIM may have adverse ef-
fects, which decrease the physical perfor-
mance of patients, especially in commu-
nity-dwelling elderlypeople over 80 years
of age [13]. The physical performance
decreased more in patients taking two
or more inappropriate drugs in compar-
ison with non-users or patients taking
only one inappropriate drug, indicating
that the association between impaired
physical performance and PIM becomes
strongerwhen thenumberof inappropri-
ate drugs increases. Users of PIM were
more likely to have cognitive impairment
in comparison with non-users, were less
likely to be physically active, and had
a higher number of medications.
To identify PIM most of the previous
studies used the criteria of Beers [4], a list
of medications that should be avoided in
elderly patients due to frequent adverse
drug events; however, the drugs on the
Beers list are mostly administered in the
USA and are not available in Europe. Al-
ternatives in theEuropeansetting include
the Priscus list [11], a list of medications
administered in Germany that should
be avoided, the Screening Tool to Alert
doctors to the Right Treatment (START)
or the Screening Tool of Older Persons’
potentially inappropriate Prescription
(STOPP), which focus on avoiding inap-
propriate drugs (STOPP) or to identify
undertreatment medications (START)
[10]. Gallagher and O’Mahoney showed
that the STOPP criteria identiﬁed a sig-
niﬁcantly higher proportion of patients
requiring hospitalization as a result of
PIM-related adverse events than Beers’
criteria [9].
Rehabilitation is known to have a ben-
eﬁcial eﬀect on the physical performance
of elderly patients [15]. Baztán et al.
showed that patients cared for in acute
geriatric rehabilitation units were more
likely to live at home after discharge, and
that the eﬀectsweremaintained3months
afterdischarge [3]. Inanothermeta-anal-
ysis Bachmann et al. found that inpa-
tient rehabilitation speciﬁcally designed
for geriatric patients has the potential
to improve outcomes regarding function
(Barthel index), nursing home admis-
sions and mortality [1]. Inpatient reha-
bilitation was signiﬁcantly more bene-
ﬁcial regarding functional outcomes at
discharge and in the long term. In a co-
hort study over a period of 12 months
Bellelli et al. showed that advanced age,
living alone, cognitive impairment, delir-
ium and poor functional status at dis-
charge from a rehabilitation unit were
the main predictors of subsequent insti-
tutionalization [5]. Multimorbidity and
delirium were predictors of rehospital-
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ization. Multimorbidity, often leading
to (inappropriate) polypharmacy, is fur-
thermore a predictor for mortality and
shouldbe considered at discharge for sec-
ondary prevention programs [5]; how-
ever, it is unknown whether PIM at ad-
mission to geriatric inpatient rehabilita-
tion has an association with rehabilita-
tion outcome. In a recently published
study mobility was the main predictor
for successful return home after inpa-
tient geriatric rehabilitation [12].
The purpose of this study was to in-
vestigate the associationof PIMat admis-
sion to an inpatient rehabilitation pro-
gram with the outcome of rehabilitation
regardingmobilityandqualityof life. The
hypothesis was that patients taking PIM
would have a less favorable rehabilitation
outcome regarding mobility and quality
of life than patients not taking PIM.
Methods
Design
This prospective, single center, cohort
studywas conducted in the rehabilitation
center Walenstadtberg (Kliniken Valens,
Switzerland), a clinic for geriatric inpa-
tient rehabilitation. This study was part
of a study to evaluate predictive factors
for living at home after geriatric rehabili-
tation [12]. A sample size of 120 patients
was required for the analysis, with 60 ad-
ditional patients to account for loss to
follow-up. Patients were recruited con-
secutivelybetweenFebruaryandNovem-
ber 2014. Recruitment exceeded expec-
tations and a ﬁnal total of 210 patients
were included.
Geriatric rehabilitation
A standardized geriatric assessment, to-
gether with individual goal setting, was
performed to plan rehabilitation inter-
ventions. Patients received a mean of
3 treatment sessions per day (in total 2 h
per day), 6 days per week, for 3 weeks.
Treatment was based on patient needs
and included individual physical and
occupational therapy, medical exercise
training, aquatic exercise and passive
modalities. The indications for any
treatment, including medication, was
the responsibility of the interdisciplinary
rehabilitation team.
Subjects
All patients aged 65 years or more who
were referred for geriatric inpatient reha-
bilitation were eligible to enter the study.
Inclusion criteria were suﬃcient under-
standing of the German language to an-
swer the questionnaires and to provide
written informed consent. Exclusion cri-
teria were medical conditions that inter-
feredwithcompletingthestudyquestion-
naires, e. g. severe psychiatric disorders,
dementia, and severe hearing and visual
impairments.
Data collection
Immediately after admission to the reha-
bilitation centre, the list of drugs taken
by the participants was checked by a re-
searcher (M. Bachmann), based on the
referral letter or the individual medica-
tion scheme, and based on the admis-
sion diagnosis assessed according to the
STOPP criteria [10] regarding appropri-
ateness. Any doubts regarding indica-
tions for the medications were discussed
and resolved in agreement with a clini-
cian experienced in geriatric rehabilita-
tion (S. Bachmann). The cohort was then
separated into two groups: one group of
patientswithoutPIMand theothergroup
with PIM, deﬁned as at least one PIM.
Assessments
In both groups baseline demographic
data regarding age, sex, education, mari-
tal status, housing situation, need for so-
cial support (modiﬁedmedical outcomes
study social support survey; mMOS-SSS
[18]) and the principalmedical diagnosis
according to the International Classiﬁ-
cation of Diseases and Related Health
Problems (ICD-10) were recorded at ad-
mission. Furthermore, cognition (mini-
mental state examination, MMSE [8]),
activities of daily living (ADL and self-
care index Selbstpﬂege-Index SPI from
ePA-AC [ergebnisorientiertes Pﬂege-
Assessment AcuteCare; 2]) and vulner-
ability (vulnerable elders survey, VES-
13 [22]) were also assessed.
Within the ﬁrst 3 days after admission
the quality of life (EQ-5D index, EuroQol
group) [6] and comorbidities (cumula-
tive illness rating scale; CIRS) [14] were
assessed. To assess mobility, the timed
up and go (TUG) test [17] was used. To
enable analysis of all patients including
those who were unable to stand up or
walk, the results of the TUG were re-
coded into an ordinal scale according to
the study by Kool et al. [12]. A time of
up to 10 s was coded as 1, 11–20 s as 2,
21–30 s as 3, 31 s or more as 4 and un-
able to perform test as 5. At discharge the
MMSE, SPI, EQ-5D index and TUG tests
were repeated. Diﬀerences between the
groups were compared regarding assess-
ment results at admission vs. assessment
results at discharge. Furthermore, asso-
ciations between the independent vari-
ables, the number of PIM, and the de-
pendent variables (changes in mobility
and quality of life) were evaluated.
Statistical analysis
Between-group comparisonsofdatawith
a normal distribution were performed
with the two-tailed Student’s t-test. Sig-
niﬁcance level was set at p < 0.05. Be-
cause the number of PIMs was not nor-
mally distributed and mobility was as-
sessed with an ordinal scale, we used
Spearman’s correlations to analyze the as-
sociation between the number of PIMs
and the change in mobility and quality of
life. Improvements in mobility and qual-
ity of life during geriatric rehabilitation
depend on multiple factors; therefore,
signiﬁcant (p < 0.05) correlations >0.1
were considered relevant. Analyses were
performed with SPSS version 22 (SPSS,
Chicago, IL, USA).
Results
Recruitment and patient
characteristics
Intheperiod fromFebruarytoNovember
2014 a total of 305 patients were assessed
for study eligibility, of whom 95 were
excluded. The main reasons for exclu-
sionwere not consenting to participation
(n = 48) and insuﬃcient understanding
of German (n = 15) preventing the com-
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Abstract
Background. Higher age is associated
with multimorbidity, which may lead to
polypharmacy and potentially inappropriate
medication (PIM).
Objective. To evaluate whether PIM on
admission for geriatric inpatient rehabilitation
is associated with rehabilitation outcome
regarding mobility and quality of life.
Material andmethods. A total of 210 patients
were included. Medications at hospital admis-
sion were analyzed with the Screening Tool
of Older Persons’ potentially inappropriate
Prescriptions (STOPP) and the number of
PIMs individual patients were taking was
determined. The study population was
then divided into two groups, one with and
one without PIM. The main rehabilitation
outcomes, quality of life and mobility,
were assessed on admission and discharge.
Associations between PIM and the main
outcomes were analyzed using the two-tailed
Student’s t-test and Spearman correlations.
Results. In total 131 PIMs were identiﬁed
by STOPP. Of the patients 91 (43%) were
taking at least 1 PIM, and 119 patients (57%)
were not taking any PIM. Patients with no
PIM had a signiﬁcantly better quality of life
on admission (p < 0.05) and discharge (p <
0.005). The number of PIMswas not associated
with the rehabilitation outcomes mobility
and quality of life (Spearman’s ρ = –0.01, p =
0.89 and ρ = –0.02, p = 0.7, respectively).
The quality of life and mobility increased
identically in both groups from admission
to discharge but the group with PIM did not
reach the levels of those without PIM.
Conclusion. The use of PIM may have
a negative impact on the quality of life of
elderly people but patients with and without
PIM achieved comparable improvements in
quality of life and mobility. Further studies are
required to assess the long-term outcomes
of patients taking PIM following inpatient
rehabilitation.
Keywords
Rehabilitation · Quality of life · Outcome
assessment · Prospective study · Mobility
Zusammenhang potenziell nichtgeeigneter Medikationmit den Ergebnissen einer stationären
geriatrischen Rehabilitation. Eine prospektive Kohortenstudie
Zusammenfassung
Hintergrund. Multimorbidität im höheren
Alter kann zu Polypharmazie und potenziell
nichtgeeigneter Medikation („potentially
inappropriatemedication“, PIM) führen.
Ziel. Prüfung eines Zusammenhangs zwischen
PIM bei Eintritt in die Rehabilitationsklinik
und den Resultaten bezüglich Mobilität
und Lebensqualität nach einer stationären
geriatrischen Rehabilitation.
Material und Methoden. Es wurden
210 Patienten in die Studie aufgenommen.
Die Eintrittsmedikationwurde gemäß den
Kriterien des Screening Tool of Older Persons’
potentially inappropriate Prescriptions
(STOPP) überprüft. Die Studienteilnehmer
wurden anschließend in 2 Gruppen zugeord-
net, eine mit und eine ohne PIM. Die Haupt-
Outcomes Mobilität und Lebensqualität
wurden bei Ein- und Austritt erhoben.
Zusammenhänge zwischen PIM und den
Hauptresultatenwurden statistischmit dem
Student’s t-Test und mithilfe der Spearman-
Korrelationen überprüft.
Ergebnisse. Gemäß den STOPP-Kriterien
wurden 131 PIM identiﬁziert. Es wiesen
91 Patienten (43%) mindestens eine PIM auf,
119 Patienten (57 %) erhielten keine PIM.
Patienten ohne PIM hatten eine signiﬁkant
bessere Lebensqualität bei Klinikeintritt (p <
0,05) und -austritt (p < 0,005). Die Anzahl
der PIM zeigte keinen Zusammenhang mit
den Rehabilitation-OutcomesMobilität und
Lebensqualität (Spearman ρ = –0,01, p =
0,89 respektive Spearman ρ = –0,02, p =
0,7). Für beide Gruppen ergab sich eine
identische Verbesserung der Mobilität und der
Lebensqualität von Ein- zu Austritt, aber die
Patientenmit PIM erreichten nicht dieselben
Mobilitäts- und Lebensqualitätslevel wie
Patienten ohne PIM.
Diskussion. „Potentially inappropriate
medication“ kann einen negativen Eﬀekt auf
die Lebensqualität älterer Menschen haben,
aber Patientenmit und ohne PIM erreichten
eine vergleichbare Verbesserung der Lebens-
qualität und der Mobilität. Weitere Studien
sind notwendig um den Langzeiteinﬂuss von
PIM nach einer stationären Rehabilitation zu
untersuchen.
Schlüsselwörter
Rehabilitation · Lebensqualität · Outcome-
Assessment · Prospektive Studie · Mobilität
pletion of questionnaires. During the
rehabilitation program 14 patients with-
drew their informed consent and 22 pa-
tients underwent unplanned transfer to
an acute hospital due to acute deterio-
ration of their health status; therefore,
data from 174 patients were analyzed
(. Fig. 1).
Demography
Details of the baseline characteristic of
both groups are presented in . Table 1.
Of the patients 113 were male with a
meanageof76.2years (SD10.0years)and
97 were female with a mean age of 74.8
years (SD 6.6 years). The main diagnosis
was osteoarthritis, followed by spinal dis-
eases, fractures and pulmonary diseases.
Further diagnoses were cancer, cardio-
vascular diseases, other internal diseases
and inﬂammatory rheumatoid diseases.
Analysis of all medications based
on the referral letter according to the
STOPP criteria revealed that 91 patients
(43%) took at least 1 PIM, and 119 pa-
tients (57%) did not take any PIM. In
the group taking PIM there were more
males than females (68 vs. 51), while in
the group who did not take any PIM
there were slightly more females than
males (45 vs. 46). The mean age in
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Patients referred for inpatient geriatric 
rehabilitation from February 
to November 2014
Assessed for eligibility 
(n=305)
Excluded (n=95)
• no informed consent (n=48)
• communication in German 
insufficient (n=15)
• insufficient general condition, 
(dizziness, severe diarrhea, 
severe pain) (n=9)
• severe psychiatric disorders
(major depression) (n=6)
• readmission to hospital before 
first appointment (n=5)
• palliative care (n=4)
• severe cognitive limitations (n=4)
• hearing/visual impairments (n=4)
Included and 
assessed for 
PIM (n=210) 
With PIM
(n= 91)
Without PIM
(n=119)
Admission 
assessments (n=119)
Admission 
assessments (n=91)
Standardized rehabilitation 
program
Discharge assessments
(n=78)
Discharge assessments
(n=96)
Analysis (n=174)
Missing (n=36)
• 14 informed consent 
withdrawn
• 22 unplanned transfers to 
acute hospital
Fig. 19 Patient recruit-
ment, study ﬂow anddata
collection. PIMpotentially
inappropriatemedication
both groups was the same. A total of
110 patients without PIM were referred
to rehabilitation after an acute hospital
stay, whereas 78 patients taking PIM
came from an acute hospital. Only 9 pa-
tients not taking PIM came from their
own home and 13 patients in the group
with PIM. Regarding type of residency
prior to acute hospital or rehabilitation,
more patients with PIM were living in
nursing homes (4.9% vs. 1.8%).
Potentially inappropriate
medications (PIM)
In total 131 PIM were identiﬁed by us-
ing the STOPP criteria, 60 people had
1 potentially inappropriate prescription
(65.93%) and 31 patients had 2 (27.47%)
or more (6.59%). The highest number
of PIM according to the STOPP crite-
ria were found in the category “central
nervous system and psychotropic drugs”,
with48PIM.Themaindrugsinthisgroup
were benzodiazepines and neuroleptics,
the category “cardiovascular system” fol-
lowed with 39 PIM, mostly concerning
beta-blockers and diuretics. Further de-
tails are shown in . Table 2.
Rehabilitation outcomes
The CIRS score, the VES-13 score and
the SPI at admission were signiﬁcantly
diﬀerent between the groups (p < 0.05),
showing that the group without PIM had
less comorbidities, was less vulnerable
and less handicapped in ADL than the
groupwith PIM (. Table 1). At discharge
these diﬀerences regarding VES-13 score
and SPI were unchanged (p < 0.05).
Analysis of the EQ-5D index showed
signiﬁcant diﬀerences at admission (p <
0.05) and discharge (p < 0.005), indicat-
ing that theparticipantswithout PIMhad
a signiﬁcantly better quality of life than
those with PIM (. Table 3). Data for the
TUG also showed better results in the
group without PIM; however, these dif-
ferences were not signiﬁcant. Changes in
mobility and quality of life were compa-
rable in patients with and without PIM
(. Fig. 2).
Although there was a diﬀerence be-
tween the two groups at entry and dis-
charge regarding mobility and quality of
life, there was no association in the cor-
relation analysis between the number of
PIM and the change in mobility (Spear-
man’s ρ = –0.01, p = 0.89 and ρ = –0.02,
p = 0.7, respectively). Nevertheless, im-
provements in mobility were associated
with improved quality of life (Spearman‘s
ρ = 0.20, p = 0.01).
Discussion
To our knowledge this is the ﬁrst study
to evaluate the eﬀects of PIM at admis-
sion to a geriatric inpatient rehabilita-
tion program on rehabilitation outcomes
at discharge. In our study population
Zeitschrift für Gerontologie und Geriatrie
Table 1 Baseline characteristics of patients included in the study
Groupwithout
PIM (n = 119)
Groupwith
PIM (n = 91)
p-value
(NS=not sig-
nificant)
Women, n 68 45 NS
Men, n 51 46 NS
Age (SD), years 75.5 (6.94) 75.5 (10.45) NS
Referral from
Acute hospital, n 110 78 NS
Own home, n 9 13 NS
Place of residence (prior to acute hospital stay and/or rehabilitation)
Urban 12.10% 13.50% NS
Rural 87.90% 86.50% NS
Type of residency
Living alone 29.30% 12.40% NS
Living alone with an auxiliary person 12.90% 18.50% NS
With partner/child 42.30% 46.90% NS
With partner/child and an auxiliary per-
son
13.70% 17.30% NS
Nursing home 1.80% 4.90% NS
Diagnosis
Osteoarthritis 22.68% 18.69% NS
Cancer 16.81% 9.89% NS
Spinal diseases 14.28% 18.69% NS
Pulmonary diseases 13.45% 10.99% NS
Fractures 10.92% 16.48% NS
Other internal diseases 10.10% 12.08% NS
Cardiovascular diseases 8.40% 10.99% NS
Inﬂammatory rheumatoid diseases 3.36% 2.19% NS
Duration of stay (SD), days 20.76 (11.25) 22.08 (8.93) NS
mMOS–SSS (SD)
(scale 19–95; 95 = best social support)
34.55 (6.65) 34.03 (7.21) NS
MMSE (SD)
(scale 0–30; >26 cognition unimpaired)
26.49 (2.76) 26.15 (3.21) NS
CIRS (SD)
(scale 0–56; 56 maximum illness load/
comorbidity)
11.13 (6.02) 13.24 (6.61) 0.02
VES-13 (SD)
(scale 1–10; ≥3 = vulnerable)
4.49 (2.99) 5.38 (2.80) 0.02
SPI (SD)
(scale 0–40; 40 = fully independent)
37.08 (3.46) 35.77 (4.99) 0.03
PIM potentially inappropriate medications, mMOS-SSS modified medical outcomes study social
support survey,MMSEmini-mental state examination, CIRS cumulative illness rating scale, co-mor-
bidities, VES-13 vulnerable elders survey, SPI self-care index (Selbstpflege-Index) and ADL activities
of daily living, SD standard deviation
43% of patients were taking at least one
PIM at admission. Patients without PIM
had a signiﬁcantly better quality of life
at admission (p < 0.05) and discharge
(p < 0.005); however, during rehabili-
tation the quality of life and mobility of
patients with and without PIM increased
identically, and the number of PIM was
not associated with these rehabilitation
outcomes.
In the study of Mann et al. the main
group of PIM in Austrian nursing homes
wasantipsychoticdrugs, followedbyben-
zodiazepines, non-steroidal anti-inﬂam-
matory drugs (NSAIDs) and opiates [16].
The main groups of PIMs in our study
were antipsychotic drugs and benzodi-
azepines, followed by beta-blockers and
diuretics. In the multicenter Austrian
study by Mann et al. [16] with 1844 pa-
tients, the prevalence of residents taking
at least one PIM was 70.3%, whereas in
our population only 43.3% of the pa-
tients were taking PIM. This diﬀerence
may arise from the fact that diﬀerent pa-
tient populations were studied. Our pa-
tients were community-dwelling persons
needing inpatient rehabilitation after an
acute hospital stay because of illnesses
or an operation, whereas Mann et al. as-
sessed PIM in a nursing home setting.
Besides the frequency of PIM, there were
nomajordiﬀerencesregardingthegroups
according to the STOPP criteria. In both
settings antipsychotic drugs and benzo-
diazepineswere themostprescribedPIM.
Fialová et al. showed in anoutpatient set-
ting that older people and those living
alone were more likely to be taking one
or more PIM [7]. Overall, the mean age
of the study population was 82.2 years,
the majority of patients were women and
most livedalone. Polypharmacywasdoc-
umented in 51%of patients, and 19.5%of
patients were taking at least one inappro-
priate medication. The patients included
in our groupwere slightly younger (mean
age 75.5 years) and, in contrast to other
studies, moremenwere taking PIM.This
might reﬂect the fact thatmen in Switzer-
land are slightly more prone to a worse
health status thanwomen [23]. We found
no major diﬀerences compared with the
results of the study by Gallagher et al.
who ﬁrst published information on the
STOPP criteria [9]. The study popula-
tion of Landi et al. is also comparable
to ours, since they included a total of
364 patients [13] and 26% (n = 94) were
taking at least 1 inappropriate medica-
tion. ThemostfrequentlyprescribedPIM
were benzodiazepines, followed by anti-
hypertensive drugs. Both drug groups
(central nervous system drugs and car-
diovascular drugs) were also the most
prominent PIM in our cohort. Onder
et al. showed that during a hospital stay
28.6% of patients were taking inappro-
priate drugs, 23% took 1 inappropriate
drug and 5.6% took 2 or more inappro-
priate drugs [19]. In this acute hospital
setting, the intake of PIM had no signiﬁ-
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Table 2 Details of the distribution of potentially inappropriatemedications (PIM) according to
Screening Tool of Older Persons’ potentially inappropriate Prescription (STOPP) criteria [10]
Category Number
of PIM
Most frequently used substance recorded
Central nervous system and psy-
chotropic drugs
48 Lorazepam, bromazepam, ﬂupen-
tixol+melitracen, quetiapine, pipamperone
Cardiovascular system 39 Bisoprolol, aspirin, furosemide, torasemide
Gastrointestinal system 29 Proton pump inhibitors (PPI)
Analgesic drugs 8 Oxycodone
Musculoskeletal system 5 Non-steroidal anti-inﬂammatory drugs
(NSAID), etodolac, diclofenac, mefenamic
acid, naproxen
Respiratory system 2 Prednisone, ipratropium+salbutamol
Urogenital system 0 –
Endocrine system 0 –
Drugs that adversely aﬀect those
prone to falls (>1 fall in past
3 months)
0 –
Duplicate drug classes 0 –
Total 131 –
Table 3 Main outcomes of EQ5D and TUG tests in bothgroups at admission anddischarge
Without PIM
Mean (SD)
With PIM
Mean (SD)
p-value
EQ-5D index
(1 = best level of quality of life)
At admission 0.69 (0.26) 0.61 (0.28) 0.045
At discharge 0.87 (0.15) 0.78 (0.22) 0.003
TUG
(coded to 1–5, where 1 = best mobility and 5=unable to perform the test)
At admission 2.41 (1.22) 2.70 (1.24) 0.09
At discharge 2.11 (1.12) 2.37 (1.17) 0.10
PIM potentially inappropriate medications, EQ-5D EuroQol group 5 dimensions, TUG timed up and
go test
cant eﬀect on hospital outcomes, such as
mortality, length of stay, or adverse drug
reactions.
In our study population, patients who
were not taking any PIM had a signiﬁ-
cantly better quality of life at admission
and discharge than patients who were
taking PIM. Furthermore, patients who
were not taking any PIM were less im-
paired at admission and discharge and
more independent at the end of the reha-
bilitation. Interestingly, the group with
PIM showed a signiﬁcantly higher co-
morbidity index at admission than the
group who were not taking any PIM,
perhaps indicating that a higher illness
load may directly lead to an increase in
medications and therefore also to taking
medications that potentially are not indi-
cated. Nevertheless, it seems that PIMdo
nothave anegative impact on the rehabil-
itationcourse, asqualityof lifeandmobil-
ity increased identically in both groups
from admission to discharge. Patients
with PIM generally had lower levels of
increasedquality of life andmobility than
those without PIM. Landi et al. showed
that community-dwelling older persons
in Italy taking PIM had a signiﬁcant neg-
ative association regarding physical per-
formance [13]. Patients who were taking
PIM were less likely to be physically ac-
tive and showed poorer results in the
short physical performance battery. In
another study from Runganga et al. in
a post-acute outpatient transitional care
setting, which is designed to facilitate
transitions from hospital to home for
older people in Australia [20], polyphar-
macy (5–9 drugs) was observed in 46.7%
of patients. Themost prevalent PIMwere
antidepressants. Polypharmacy was as-
sociated with frailty, falls and poor func-
tional outcomes. Finally, regarding func-
tion a study from Tosato et al. [24]
showed that in geriatric care wards (geri-
atric evaluation and management units)
a decline in physical function was more
often identiﬁed in patients taking PIM.
The decline in function increased with
the number of PIM used. Our results are
in linewithall theseﬁndings; ourpatients
with PIM also seemed to be more im-
paired than patients who were not taking
any inappropriate drugs. Although pa-
tients with PIMhad lowermobility levels
at baseline and after rehabilitation, cor-
relation analysis revealed no statistical
association between PIM and mobility;
however, the mobility of patients taking
PIM at hospital entry did not increase
to the same outcome level reached by
patients who were not taking any PIM
despite the fact that they underwent the
same rehabilitation program; this might
lead to poorer outcomes in the long term.
Finally, one could argue that rather than
PIMthedisease itselfmayhavealtered the
outcome results, since diﬀerent diseases
may have diﬀerent disease courses and
therefore also diﬀerent outcomes regard-
ing quality of life and mobility; however,
in our study the main diagnoses and dis-
eases were equally distributed, with no
statistical diﬀerences at baseline. There-
fore, we believe that this possible eﬀect
of the disease itself would also have ap-
peared in the group of patients not taking
PIM.
Strengths
One of the strengths of this study is the
large sample of patients (n = 210). The
majority of patients assigned for rehabil-
itation were included in the study, thus
making the study representative of geri-
atric rehabilitation in Switzerland. We
had a complete list of medications taken
by every patient, therefore the evalua-
tion of PIM was good. Furthermore, as
we were able to stringently follow the
patients during inpatient rehabilitation
there was a low drop-out rate, and there-
fore the comparisons of the eﬀects on
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Fig. 28 Improvement inmobility andquality of life (QOL) in the groupswithout potentially inappropriatemedication (PIM)
andwith PIM at baseline and at discharge.a Changes inmobility in patientswith andwithout PIMs.Y-axis: TUG 1-5 (1=best
mobility, 5 unable toperform the test).bChanges inQOL inpatientswith andwithout PIMs.Y-axis: EQ5D-Index (1=best level
of QOL)
rehabilitation outcomes are valid in this
group of patients.
Limitations
The observation time was short and the
results presented here cover a period of
only 3–4 weeks. We do not know if the
poorer but not signiﬁcantly diﬀerent re-
sults regardingmobility andquality of life
for patients taking PIMpersist after inpa-
tient rehabilitation. Another limitation
is that we had no information regarding
when the PIMwere ﬁrst prescribed, dur-
ing the preceding hospital stay or earlier.
This might create bias regarding our re-
sults, as a longer period of taking PIM
mayhave stronger negative eﬀects, which
may lead to a poorer quality of life and
lower mobility, depending on the pre-
scribed medication. In addition, if the
drug was given in the preceding hospital
for theﬁrst time, PIMmay lead to adverse
drug reactions, such as delirium, which
also may alter quality of life and mobil-
ity. Finally, the results presented here
may not be generalized, since approxi-
mately 90% of all our patients came to
rehabilitation after an acute hospital stay.
The results are best applicable to similar
patients. We assume lower generalizabil-
ity, e. g. to medically stable persons over
65 years of age, independently living at
home, with lower comorbidity and lower
PIM rates.
Conclusion
Overall, the results indicate that inappro-
priate drugs should be monitored with
care, as they may have a negative impact
on the mobility and quality of life of el-
derly people. Together with the results of
our study, all published evidence so far
shows that inappropriate drugs are ad-
ministered to a high proportion of older
people, and that this may lead to lower
levels of mobility and poorer quality of
life.
Further implications
Further research is needed into the long-
term outcomes of inpatient rehabilita-
tion in patients receiving PIM, e. g. in
a randomized clinical trials comparing
rehabilitation with and without a spe-
cial focus on PIM reduction and with
1-year follow-up after inclusion. Future
research should also focus on the ques-
tion as to whether outcomes in the long
term are better when PIM use is cor-
rected in the acute hospital setting. Since
PIM seem to have a negative correlation
with mobility and quality of life, a long-
term cost analysis should be performed
to determine whether use of PIM also
has a negative correlation with medical
and societal costs.
Practical conclusion
4 PIM are frequently found at hospital
admittance for inpatient rehabilita-
tion (43% of all patients).
4 PIM are associated with lower mo-
bility and quality of life, but patients
with and without PIM achieved com-
parable improvements in mobility
and quality of life.
4 Medications for elderly people should
be monitored on a regular basis to
identify and correct PIM, as they may
have a negative impact on mobility
and quality of life.
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